arXiv:2606.07239v1 Announce Type: new Abstract: The success of generative molecular design hinges on a model's steerability toward high-reward samples. Because many molecular properties are intrinsically linked to molecular size, accurately capturing the joint distribution of properties and the number of atoms is essential. However, current diffusion and flow-based models fix the number of atoms, which ultimately limits their ability to navigate this complex relationship. To address this, we introduce Morph, a flexible-size generative model for conditional and unconditional 3D molecular design
The continuous advancements in AI and generative models are expanding their applications into complex scientific domains like molecular design, driven by the need for more efficient drug discovery and material science.
This development represents a significant step towards more flexible and steerable generative AI for molecular design, which can accelerate the discovery of novel compounds with desired properties, impacting pharmaceuticals, materials, and energy.
Current generative molecular design models are limited by fixed molecular sizes; this new approach allows for flexible-size generation, enabling the exploration of a much wider and more relevant chemical space.
- · Pharmaceuticals
- · Biotechnology
- · Material Science
- · AI/ML researchers in chemistry
- · Traditional drug discovery methods
- · Companies reliant on fixed-size molecular models
More efficient discovery of new drugs and advanced materials becomes possible.
Reduced R&D costs and shortened timelines for developing novel therapeutics and industrial compounds.
New classes of materials and medicines emerge, potentially leading to significant economic shifts and improvements in human health.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG